GEN Exclusives

More »

GEN News Highlights

More »
Jan 12, 2007

Chromos and Genitope Sign Cell Line Engineering Contract

  • Chromos Molecular Systems entered into a cell line engineering service agreement with Genitope to develop a cell line using Chromos’ ACE system for potential use in the clinical and commercial manufacture of a biopharmaceutical product.

    Specifically, Chromos will engineer cell lines for the expression of a Mab for Genitope. According to Chromos, recent data generated by one of its partners has shown that cell lines engineered using ACE are capable of achieving Mab yields of greater than 4 g/L in a nonoptimized bioreactor system, a four-fold improvement over the partner’s original cell line.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

Be sure to take the GEN Poll

Cancer Drug Approvals and Efficacy

Do you think regulatory agencies should be required to provide stronger evidence of the clinical effectiveness of cancer drugs, including a greater emphasis on patient survival time?

More »